Table 4 Comparing mIFG for major adverse events and mortality alone in the derivation and validation group
From: Development and validation of the modified index of fragility in head and neck cancer surgery
| Â | Derivation set | Validation set | ||||||
|---|---|---|---|---|---|---|---|---|
Major AEa | Death | Major AEa | Death | |||||
OR (95% CI) | AUC (95% CI) | OR (95% CI) | AUC (95% CI) | OR (95% CI) | AUC (95% CI) | OR (95% CI) | AUC (95% CI) | |
mIFG score 1 | 1.99 (1.81–2.19) | 0.64 (0.63–0.65) | 2.54 (1.64–3.94) | 0.73 (0.69–0.77) | 1.93 (1.67–2.23) | 0.64 (0.63–0.66) | 1.69 (0.89–3.24) | 0.70 (0.63–0.76) |
mIFG score 2 | 4.13 (3.64–4.67) |  | 5.81 (3.61–9.24) |  | 3.29 (2.74–3.95) |  | 4.15 (2.14–8.04) |  |
mIFG score 3 | 6.69 (5.54–8.08) |  | 11.56 (6.67–19.44) |  | 6.02 (4.53–8.00) |  | 9.41 (4.40–20.1) |  |
mIFG score 4+ | 7.11 (5.02–10.08) |  | 27.52 (13.88–51.26) |  | 8.80 (5.1–15.13) |  | 10.8 (3.61–32) |  |